The Evoke® System Is The Only SmartSCS™ Therapy For Chronic Pain
While spinal cord stimulation (SCS) therapy has been around for more than 50 years, there’s a smarter treatment option that can help you regain your life. The Evoke® System listens to your body’s needs and automatically adjusts therapy in real time so that you can focus less on your pain and more on living your life.
Dana’s Story
The Evoke® stimulator has impacted my life by allowing me to return to work…it has allowed me to continue to do outdoor activities.
Dana S.
Evoke® System patient
What Is The Evoke® SmartSCS™ System?
It’s a small device that safely works inside your body to provide lasting pain relief and restore your quality of life.1
- Safe, Non-Drug Therapy
- Minimally Invasive
- Try Before You Decide
- Simple Outpatient Procedure
The Evoke® System is smart because it constantly listens to your body’s needs and automatically adjusts therapy 4+ million times per day*
A Proven Treatment
The most durable patient outcomes from a randomized control study in SCS history with 36-month data 1
The Evoke® System was approved based on the most rigorous clinical study in the history of spinal cord stimulation of 134 patients.
Saluda Medical’s Evoke® SCS System delivered pain relief and clinically superior therapy1. The EVOKE Study reported industry-leading quality of life outcomes, when compared to current SCS systems.
The Centers for Medicare and Medicaid Services (CMS) has stated, “We believe this RCT (EVOKE Study)comparison served to demonstrate substantial clinical improvement” over existing SCS devices and created a new device category for Medicare reimbursement.
2023 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Final Rule, the Department of Health and Human Services, Centers for Medicare and Medicaid Services.
You Are Able To Trial The Evoke® System Before Deciding To Get The Permanent Implant
- One of the advantages of SCS therapy is that you can try it before deciding on a permanent implant.
- The goal of the trial is to reduce your pain by at least 50% and improve your ability to do the things you find challenging due to your pain.
- In the Clinical Study for FDA approval of the Evoke® System, 83% of patients experienced a 50% or greater reduction in pain and 59% of patients experienced a 80% or greater reduction in pain, as well as improvements in quality of life, functional status, mood and sleep. 1
Impact Of The Evoke® System On Patients
Additional Resources
Evoke System Patient Overview Brochure
Evoke System Patient Trifold Brochure
Getting an MRI Scan Brochure
Evoke System Patient Overview Brochure Spanish